VIJAYAWADA: The State government is committed to ensuring uninterrupted care for citizens with rare and chronic disorders ...

Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

Treatment options for children with hemophilia A have expanded with the FDA approval of Bayer's Jivi antihemophilic factor ...

The company said the discontinuation was due to several reasons,” Reuters news service reported, “including limited interest ...

Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...

Jivi first received FDA approval in August 2018. The approval was for use in previously treated adults aged 12 and older who have hemophilia A. The uses included on-demand treatment and control of ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

Novel treatment restores natural clotting balance and helps reduce bleeding episodes in people with hemophilia ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...